Comments
Loading...
Immunovant (IMVT) Forecast
NewsEarningsImmunovant (IMVT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestImmunovant (NASDAQ:IMVT) Stock Quotes, Forecast and News Summary
Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immunovant (IMVT) stock?
You can purchase shares of Immunovant (NASDAQ:IMVT) through any online brokerage.
Who are Immunovant (IMVT) competitors?
Other companies in Immunovant’s space includes: Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), Alkermes (NASDAQ:ALKS) and PTC Therapeutics (NASDAQ:PTCT).
What is the forecast, or price target, for Immunovant (IMVT) stock?
Immunovant has a consensus price target of $40.68.
What is the current price for Immunovant (IMVT)?
The stock price for Immunovant (NASDAQ: IMVT) is $27.45 last updated December 18, 2024 at 2:00 PM EST.
Does Immunovant (IMVT) pay a dividend?
There are no upcoming dividends for Immunovant.
When is Immunovant (NASDAQ:IMVT) reporting earnings?
Immunovant’s Q3 earnings are confirmed for Monday, February 10, 2025.
Is Immunovant (IMVT) going to split?
There is no upcoming split for Immunovant.
What sector and industry does Immunovant (IMVT) operate in?
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.